Refine search

Date
Tumour Site
Topics
Congress

671 results for ""

Novel concepts on the horizon for the diagnosis and treatment of mesothelioma

Novel concepts on the horizon for the diagnosis and treatment of mesothelioma

Malignant pleural mesothelioma is a rare and fatal disease with very little improvement in survival in recent years, mirroring very limited therapeutic advances. After a long-awaited time, improvement in patient survival was achieved with the introduction of nivolumab plus ipilimumab in the first-line setting, as demonstrated in the CheckMate 743 trial.

    By
  • Alessandra Curioni Fontecedro
Rare tumours make it to a Presidential Symposium

Rare tumours make it to a Presidential Symposium

Rare tumours have been neglected for decades, with lack of funding, lack of research and lack of visibility. It is encouraging to see how this is changing and how research in rare tumours is not only taking place, but also being highlighted in Presidential Symposium 3 at this year’s ESMO Congress.

    By
  • Angela Lamarca

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.